Nanosphere induced gene expression in human dendritic cells

Nano Letters

Volumn 5, Issue 11, 2005, Pages 2168-2173

  Matsusaki, Michiya ^a   Larsson, Kristina ^b   Akagi, Takani ^c   Lindstedt, Malin ^b   Akashi, Mitsuru ^a   Borrebaeck, Carl A K ^b  

^a OSAKA UNIVERSITY   (Japan)

^b LUND UNIVERSITY   (Sweden)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; CELLS; GENES; IMMUNOLOGY; VACCINES;

DENDRITIC CELLS; IMMUNE RESPONSE; NANOSPHERE; NASAL VACCINATION;

NANOSTRUCTURED MATERIALS;

CD86 ANTIGEN; DRUG CARRIER; HLA DR ANTIGEN; NANOTUBE; TETANUS TOXOID;

ARTICLE; DENDRITIC CELL; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; IMMUNOLOGY; IN VITRO STUDY; METABOLISM; MUCOSAL IMMUNITY; PHAGOCYTOSIS;

ANTIGENS, CD86; DENDRITIC CELLS; DRUG CARRIERS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HLA-DR ANTIGENS; HUMANS; IMMUNITY, MUCOSAL; NANOTUBES; PHAGOCYTOSIS; TETANUS TOXOID;

EID: 28144450800     PISSN: 15306984     EISSN: None     Source Type: Journal    
DOI: 10.1021/nl050541s     Document Type: Article

References (32)

1. Akashi, M.; Niikawa, T.; Serizawa, T.; Hayakawa, T.; Baba, M. Capture of HIV-1 gp120 and virions by lectin-immobilized polystyrene nanospheres. Bioconjugate Chem. 1998, 9, 50-53.
2. Kaneko, T.; Shimomai, S.; Miyazaki, M.; Baba, M.; Akashi, M. IgG responses to intranasal immunization with cholera-toxin-immobilized polymeric nanospheres in mice. J. Biomater. Sci., Polym. Ed. 2004, 15, 661-669.
3. Kawamura, M.; Naito, T.; Ueno, M.; Akagi, T.; Hiraishi, K.; Takai, I., et al. Induction of mucosal IgA following intravaginal administration of inactivated HIV-1-capturing nanospheres in mice. J. Med. Virol. 2002, 66, 291-298.
4. Akagi, T.; Kawamura, M.; Ueno, M.; Hiraishi, K.; Adachi, M.; Serizawa, T., et al. Mucosal immunization with inactivated HIV-1capturing nanospheres induces a significant HIV-1 -specific vaginal antibody response in mice. J. Med. Virol. 2003, 69, 163-72.
5. Miyake, A.; Akagi, T.; Enose, Y.; Ueno, M.; Kawamura, M.; Horiuchi, R., et al. Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques. J. Med. Virol. 2004, 73, 368-377.
6. Banchereau, J.; Steinman, R. M. Dendritic cells and the control of immunity. Nature 1998, 392, 245-252.
7. Cella, M.; Sallusto, F.; Lanzavecchia, A. Origin maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 1997, 9, 10-16.
8. Croft, M.; Duncan, D. D.; Swain, S. L. Response of naive antigen-specific CD4+ T cells in vitro: characteristics and antigen-presenting cell requirements. J. Exp. Med. 1992, 176, 1431-1437.
9. Macatonia, S. E.; Hosken, N. A.; Litton, M.; Vieira, P.; Hsieh, C. S.; Culpepper, J. A., et al. Dendritic cells produce IL-12 and direct the development of Th 1 cells from naive CD4+ T cells. J. Immunol. 1995, 154, 5071-5079.
10. Riza, M.; Tokura, S.; Iwasaki, M.; Yashima, E.; Kishida, A.; Akashi, M. Graft copolymers having hydrophobic backbone and hydrophilic branches. X. Preparation and properties of water-dispersible microspheres having poly-(methacrylic acid) branches on their surface. J. Polym. Sci. Part A: Polym. Chem. 1995, 33, 1219-1225.
11. Lindstedt, M.; Johansson-Lindbom, B.; Borrebaeck, C. A. Global reprogramming of dendritic cells in response to a concerted action of inflammatory mediators. Int. Immunol. 2002, 14, 1203-1213.
12. Huang, Q.; Liu, D.; Majewski, P.; Schulte, L. C.; Korn, J. M.; Young, R. A., et al. The plasticity of dendritic cell responses to pathogens and their components. Science 2001, 294, 870-875.
13. El Mezgueldi, M.; Tang, N.; Rosenfeld, S. S.; Ostap, E. M. The kinetic mechanism of Myole (human myosin-IC). J. Biol. Chem. 2002, 277, 21514-21521.
14. van der Flier, A.; Kuikman, L; Kramer, D.; Geerts, D.; Kreft, M.; Takafuta, T., et al. Different splice variants of filamin-B affect myogenesis, subcellular distribution, and determine binding to integrin [beta] subunits. J. Cell Biol. 2002, 756, 361-376.
15. Harada, A.; Sekido, N.; Akahoshi, T.; Wada, T.; Mukaida, N.; Matsushima, K. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J. Leukoc. Biol 1994, 56, 559-564.
16. Nishimoto, N.; Kishimoto, T.; Yoshizaki, K. Anti-interleukin 6 receptor antibody treatment in rheumatic disease. Ann. Rheum. Dis. 2000, 59, Suppl 1, i21-27.
17. Gauzzi, M. C.; Canini, I.; Eid, P.; Belardelli, F.; Gessani, S. Loss of type IIFN receptors and impaired IFN responsiveness during terminal maturation of monocyte-derived human dendritic cells. J. Immunol. 2002, 169, 3038-3045.
18. Boehm, U.; Klamp, T.; Groot, M.; Howard, J. C. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 1997, 15, 749-795.
19. Alexander, W. S. Suppressors of cytokine signaling (SOCS) in the immune system. Nat. Rev. Immunol. 2002, 2, 410-416.
20. Rawlings, J. S.; Rosler, K. M.; Harrison, D. A. The JAK/STAT signaling pathway. J. Cell Sci. 2004, 117, 1281-1283.
21. Liu, B.; Mink, S.; Wong, K. A.; Stein, N.; Getman, C.; Dempsey, P. W.; et al. PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity. Nat. Immunol 2004, 5, 891-898.
22. Medzhitov, R. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 2001, 1, 135-145.
23. Akira, S.; Takeda, K.; Kaisho, T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol 2001, 2, 675-680.
24. Arbibe, L.; Mira, J. P.; Teusch, N.; Kline, L.; Guha, M.; Mackman, N.; et al. Toll-like receptor 2-mediated NF-kappa B activation requires a Racl-dependent pathway. Nat. Immunol. 2000, 1, 533-540.
25. Visintin, A.; Mazzoni, A.; Spitzer, J. H.; Wyllie, D. H.; Dower, S. K.; Segal, D. M. Regulation of Toll-like receptors in human monocytes and dendritic cells. J. Immunol. 2001, 166, 249-255.
26. Parker, L. C.; Whyte, M. K.; Vogel, S. N.; Dower, S. K.; Sabroe, I. Toll-like receptor (TLR)2 and TLR4 agonists regulate CCR expression in human monocytic cells. J. Immunol. 2004, 772, 4977-4986.
27. Eswarakumar, V. P.; Lax, I.; Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 2005, 16, 139-149.
28. Patel, D. D.; Koopmann, W.; Imai, T.; Whichard, L. P.; Yoshie, O.; Krangel, M. S. Chemokines have diverse abilities to form solid-phase gradients. Clin. Immunol. 2001, 99, 43-52.
29. Moschella, F.; Maffei, A.; Catanzaro, R. P.; Papadopoulos, K. P.; Skerrett, D.; Hesdorffer, C. S., et al. Transcript profiling of human dendritic cells maturation-induced under defined culture conditions: comparison of the effects of tumour necrosis factor alpha, soluble CD40 ligand trimer and Interferon gamma. Br. J. Haematol. 2001, 114, 444-457.
30. Bowen, M. A.; Patel, D. D.; Li, X.; Modrell, B.; Malacko, A. R.; Wang, W. C.; et al. Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand. J. Exp. Med. 1995, 181, 2213-2220.
31. Mason, J. M.; Naidu, M. D.; Barcia, M.; Porti, D.; Chavan, S. S.; Chu, C. C. IL-4-induced gene-l is a leukocyte L-amino acid oxidase with an unusual acidic pH preference and lysosomal localization. J. Immunol. 2004, 173, 4561-4567.
32. Andrejeva J.; Childs K. S.; Young D. F.; Carlos T. S.; Stock N.; Goodbourn S.; et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 17264-17269.